Strategic Initiative

Slingshot members are tracking this corporate initiative:

Novartis (NVS) Agrees to Exclusive Worldwide License Agreement for Contaus Pharma's (CNAT) Orally Active Pan-Caspase Inhibitor Emricasan

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks


Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Dec 19, 2016
Projected Implementation:
Q1, 2017
Relevance Tracked Until:
Q1, 2019
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Exclusive Worldwide License Agreement, Orally Active, Pan-caspase Inhibitor, Emricasan